Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunao Shimada

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|November 16, 2019
High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17ANaoki Sugimura, Koji Otani, Toshio Watanabe, et al.
Scientific Reports|September 3, 2016
Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasomeKoji Otani, Toshio Watanabe, Sunao Shimada, et al.
Scientific Reports|December 15, 2016
NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitisShigehiro Itani, Toshio Watanabe, Yuji Nadatani, et al.
Plos One|February 21, 2019
Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damageSunao Shimada, Tetsuya Tanigawa, Toshio Watanabe, et al.
Plos One|January 28, 2021
Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiotaTetsuya Tanigawa, Toshio Watanabe, Akira Higashimori, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Scientific Reports|November 16, 2019
High-fat diet-mediated dysbiosis exacerbates NSAID-induced small intestinal damage through the induction of interleukin-17ANaoki Sugimura, Koji Otani, Toshio Watanabe, et al.
Scientific Reports|September 3, 2016
Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasomeKoji Otani, Toshio Watanabe, Sunao Shimada, et al.
Scientific Reports|December 15, 2016
NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitisShigehiro Itani, Toshio Watanabe, Yuji Nadatani, et al.
Plos One|February 21, 2019
Involvement of gliadin, a component of wheat gluten, in increased intestinal permeability leading to non-steroidal anti-inflammatory drug-induced small-intestinal damageSunao Shimada, Tetsuya Tanigawa, Toshio Watanabe, et al.
Plos One|January 28, 2021
Rebamipide ameliorates indomethacin-induced small intestinal damage and proton pump inhibitor-induced exacerbation of this damage by modulation of small intestinal microbiotaTetsuya Tanigawa, Toshio Watanabe, Akira Higashimori, et al.
Pageof 2